Bristol-Myers Squibb
PulseAugur coverage of Bristol-Myers Squibb — every cluster mentioning Bristol-Myers Squibb across labs, papers, and developer communities, ranked by signal.
- 2026-05-21 partnership Bristol-Myers Squibb is deploying Anthropic's Claude across its workforce for drug discovery and operations. source
2 day(s) with sentiment data
-
BMS Mumbai center emphasizes need for explainable AI in insurance
BMS has opened a new center in Mumbai, emphasizing the growing need for AI solutions in the insurance brokerage sector. The company highlights that to effectively scale complex operations, AI must be inherently explaina…
-
Healthcare M&A Surges to $65B Amid Patent Cliffs and Global Innovation
The pharmaceutical industry is experiencing a significant surge in mergers and acquisitions, with $65 billion in deals during the first quarter of 2026. This trend is driven by looming patent expirations for major drugs…
-
Bristol-Myers Squibb deploys Anthropic's Claude for drug discovery
Bristol-Myers Squibb, a major pharmaceutical company, is implementing Anthropic's Claude across its 30,000 employees for various functions including drug discovery and operational tasks. This partnership positions Claud…
-
Pharma leaders seek stable FDA amid pricing policy concerns
Pharmaceutical industry leaders are advocating for stability and predictability from the next Food and Drug Administration (FDA) commissioner following a period of leadership changes and uncertainty. CEOs from major dru…
-
Axios Future of Health Summit 2026 to Convene Healthcare Leaders
Axios will host its second annual Future of Health Summit on Wednesday, May 13, 2026, featuring discussions on the evolving healthcare landscape. The event will convene various leaders from the health, technology, and p…
-
Hengrui inks $15.2B global drug development deal with BMS
Chinese pharmaceutical company Hengrui has entered into a global collaboration and licensing agreement with US giant Bristol Myers Squibb (BMS). The deal, valued at up to US$15.2 billion, involves the development of 13 …
-
Innovent Biologics and Bristol Myers Squibb partner on 13 early-stage drug projects
Innovent Biologics has entered into a global strategic collaboration and licensing agreement with Bristol Myers Squibb to advance 13 early-stage projects across oncology, hematology, and immunology. This partnership aim…
-
Bristol Myers Squibb leads drug industry in AI adoption for manufacturing
Bristol Myers Squibb is an outlier among American manufacturers for its early adoption of artificial intelligence in its factories. While many companies are hesitant to integrate AI, this drugmaker is already leveraging…